Cargando…

Characteristics and clinical associations of late gadolinium enhanced cardiovascular magnetic tesonance in lamin A/C, cardiac troponin T and myosin binding protein C gene mutation related cardiomyopathies

Detalles Bibliográficos
Autores principales:	Franke, Jennifer, Seitz, Sebastian A, Abdel-Aty, Hassan, Abdelrazek, Mohamed A, Lossnitzer, Dirk, Katus, Hugo A, Andre, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559766/ http://dx.doi.org/10.1186/1532-429X-15-S1-P150

Ejemplares similares

Bio-imaging: late gadolinium enhancement in hypertrophic cardiomyopathy and its relation to novel biomarkers of fibrosis
por: Abdel-Aty, Hassan, et al.
Publicado: (2012)

Myocardial bridging in patients with hypertrophic cardiomyopathy is not associated with late gadolinium enhancement at cardiac magnetic resonance imaging
por: Hees, Tilman A, et al.
Publicado: (2013)

Comparison of the amount of affected myocardium quantified by late gadolinium enhancement and the degree of myocardial necrosis measured by cardiac troponin T in patients with myocarditis
por: Andre, Florian, et al.
Publicado: (2013)

Increase of myocardial infarctions over the years after heart transplantation detected by late gadolinium enhanced MRI
por: Braggion Santos, Maria Fernanda, et al.
Publicado: (2013)

Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy
por: Holmström, Miia, et al.
Publicado: (2011)

Bio-imaging: late gadolinium enhancement in dilated cardiomyopathy and its relation to novel biomarkers of fibrosis and remodeling
por: Abdel-Aty, Hassan, et al.
Publicado: (2013)

Diffuse myocardial fibrosis in early forms of dilated cardiomyopathy: insights from T1 mapping cardiovascular magnetic resonance
por: aus dem Siepen, Fabian, et al.
Publicado: (2013)

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis
por: Lossnitzer, Dirk, et al.
Publicado: (2010)

Right ventricular function in dilated cardiomyopathy: relation to location of focal myocardial fibrosis
por: Abdelrazek, Mohamed A, et al.
Publicado: (2013)

GEISIR: gadolinium exposure induced systemic inflammatory response in dialysis patients
por: Steen, Henning, et al.
Publicado: (2009)

Detection and prevalence of myocardial infarction early and late after heart transplantation detected by late gadolinium enhanced MRI
por: Steen, Henning, et al.
Publicado: (2012)

CMR derived MAPSE and TAPSE Measurements in hypertrophic cardiomyopathy: comparison to healthy volunteers
por: Abdel-Aty, Hassan, et al.
Publicado: (2012)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Non-invasive measurement of myocardial extracellular volume using T1 mapping as a novel biomarker of diffuse fibrosis in dilated cardiomyopathy
por: aus dem Siepen, Fabian, et al.
Publicado: (2013)

Staged cardiovascular magnetic resonance for differential diagnosis of Troponin T positive patients with low likelihood for acute coronary syndrome
por: Steen, Henning, et al.
Publicado: (2010)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2010)

Exuberant Pattern of Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
por: Fernandes, Elsa, et al.
Publicado: (2013)

Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
por: Aquaro, Giovanni Donato, et al.
Publicado: (2023)

Influence of presence and patterns of late gadolinium enhancement on left ventricular remodeling after heart transplantation
por: Braggion Santos, Maria Fernanda, et al.
Publicado: (2013)

Assessment of left and right ventricular trabeculation and non-compacted myocardium in a large selected healthy reference population
por: Andre, Florian, et al.
Publicado: (2014)

Mouse Models of Cardiomyopathies Caused by Mutations in Troponin C
por: Tikunova, Svetlana B., et al.
Publicado: (2023)

Results of Late Gadolinium Enhancement in Children Affected by Dilated Cardiomyopathy
por: Muscogiuri, Giuseppe, et al.
Publicado: (2017)

Left ventricular non-compaction cardiomyopathy in adults – characterisation by cardiac magnetic resonance imaging
por: Merten, Constanze, et al.
Publicado: (2009)

Myocardial late gadolinium enhancement in systemic lupus erythematosus as a marker of chronic inflammation
por: Braggion Santos, Maria Fernanda, et al.
Publicado: (2013)

In/opposed phase imaging effectively differentiates fat from enhanced myocardium in patients with myocardial late gadolinium enhancement
por: Kleindienst, Denise, et al.
Publicado: (2009)

Lamin A/C truncation in dilated cardiomyopathy with conduction disease
por: MacLeod, Heather M, et al.
Publicado: (2003)

Dilated cardiomyopathy produced by lamin A/C gene mutations
por: GOIDESCU, CERASELA MIHAELA
Publicado: (2013)

The Association between the Extent of Late Gadolinium Enhancement and Diastolic Dysfunction in Hypertrophic Cardiomyopathy
por: Alis, Deniz, et al.
Publicado: (2021)

Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
por: Halliday, Brian P., et al.
Publicado: (2019)

Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy
por: Smith, Brandon M, et al.
Publicado: (2013)

Stress perfusion CMR in hypertrophic cardiomyopathy: comparison with late gadolinium enhancement
por: Villa, Adriana, et al.
Publicado: (2014)

Prevalence and potential mechanisms leading to persistent elevation of high sensitive troponin T in patients 6 month after acute myocardial infarction
por: Neizel, Mirja, et al.
Publicado: (2009)

Lamin A/C Cardiomyopathy with E203K Pathogenic Mutation
por: Sheikh, Fahad N, et al.
Publicado: (2020)

Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy
por: Sano, Makoto, et al.
Publicado: (2016)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
por: O'Hanlon, Rory, et al.
Publicado: (2009)

Exuberant late gadolinium enhancement in hypertrophic cardiomyopathy as a precursor to ‘burn out’
por: Gweun, John, et al.
Publicado: (2022)

Prognosis evaluation of chronic inflammatory cardiomyopathy with ring‐like late gadolinium enhancement
por: Wang, Hui, et al.
Publicado: (2023)

Prognostic impact of late gadolinium enhancement in patients with high-sensitivity troponin elevation and non-obstructive coronary arteries
por: Johnson, Kerryanne, et al.
Publicado: (2015)

Improved prediction of adverse events in hypertrophic cardiomyopathy with quantitative late gadolinium enhancement and myocardial strain
por: Brahmanandam, Vikram, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jghcgov6rvo0n1eotsr4j0lq06